ARQT·03969K108·US·equity·Healthcare - Biotechnology-Activist
ARQT (ARCUTIS BIOTHERAPEUTICS INC) is held by 140 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($216.8M), STATE STREET CORP ($148.3M), Polar Capital Holdings Plc ($133.5M). Net institutional sentiment: Mixed.
See how ARQT's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer